Knight Therapeutics has entered into an exclusive license agreement with Amneal Pharmaceuticals giving it rights to apply…
Articles by Andrea Lobo
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded an $873,000 grant to Vesper Bio…
Centogene and The Michael J. Fox Foundation (MJFF) are teaming up on a research project to investigate genetic risk…
A new brain imaging method may help diagnose mild traumatic brain injury (mTBI), which according to some studies can be…
Monitoring symptoms at home using smartwatch-smartphone technology collected individual profiles of tremor and activity fluctuations among people with advanced…
Treatment with AB-1005 (AAV2-GDNF), AskBio’s investigational gene therapy, was safe and well tolerated among patients with mild to moderate…
Targeted ocular spectroscopy, a technology that allows real-time imaging of the back of the eye (or eye fundus) while observing…
Researchers have developed a three-dimensional brain organoid — a “mini-organ” model of the brain — that replicates a human neural…
The U.S. Food and Drug Administration (FDA) has cleared NeuroOne’s OneRF Ablation System, a brain electrode-guided tool employed in…
Amneal Pharmaceuticals and Bial have entered into a licensing agreement giving Amneal exclusive rights to market…